Ruiling Hartley Email & Phone Number

Cary, Nc, Us

• Lead company wise planning and forecasting cycles, including long range strategic planning, 3-year budgeting and quarterly update, resulting prioritization of internal pipelines and defining corporate long-term strategies and objectives. Prepare presentations for CFO to the Board and external conferences. • Lead company monthly and quarterly financial performance review to identify key business drivers and actions to deliver year end targets. Identify company financial KPIs to drive efficiency and support resource allocation. Support CFO and IR team on quarterly press release and address any potential investor questions. • Identify and lead system implementations to improve company wise financial planning and reporting processes, identifying long term system solutions and financial data integrities to improve finance analytical capabilities and building key KPIs for management to monitor company performance. • Finance partner for corporate G&A functions to drive G&A function spending efficiencies and working with all G&A function SVPs for financial management, data analysis, planning and forecasting. • Lead various strategic projects and process improvement initiatives to ensure company future scalable growth.

Cary, Nc

• Led all financial activities in US market, including daily financial operations, system implementation, tax, compliance, financial performance review, planning and financial analysis in US market. • Built US finance operation from ground up, and partner with US President to drive business growth and margin improvement. Business successfully launched new products in 9 months and realized more than 30% growth quarter over quarter. Business was cash flow positive third month since launching products in the market. • Managed all government price reporting and compliance requirements.• Managed business through Covid pandemic situation, maintained all employment and cash flow positive through the lock down period, and business returned to growth in Q3 2020.

Rtp Nc

• Lead team of 3 direct reports to manage all financial activities related to Managed Care, Medicare Part D, Institutional (Hospital) and Channel for GSK US Pharma, Vaccines and ViiV healthcare company with more than $2 billion balance sheet and $9 billion P&L impact. • Lead Managed Care, Medicare, Institutional and channel forecast to feed into each financial update and planning/budgeting. Review forecast assumptions, business drivers and future strategies with each function VPs for all forecast and budget cycles. • Lead assessment of GSK Gross to Net methodology change by working with Deloitte, internal system team and industry peers to stream line current process and comply with audit requirements. • Instrumental to set new gross to net system tool implementation requirements. Work and lead external consultants and software companies to build fit for purpose and efficient GSK system for financial operation and forecasting. • Lead team of 3 direct reports to streamline and improve efficiencies of current gross to net operation processes, reducing manual processes and improve team operational accuracies in month end and forecast.

Gsk House, Brentford, Uk

• Acted as Regional Pharma Supply Chain controller to manage overall P&L and balance sheet actuals and forecasts. Streamlined and managed corporate financial updates and planning cycles for Regional Pharma Supply Chain. Supported Finance VP and supply chain SVP in performance reviews and identify key risks and opportunities to deliver financial targets. • Finance partner in business optimization team, work closely with commercial and global planning team to optimize supply constrained products and drive volume growth for products with access capacity. Maximizing patient access and product profitability. • Lead Global Manufacturing Supply (GMS) finance and global planning to align global pharma supply and demand volume through financial update and plan process. Design the process into integrated financial planning project, evolving corporate financial planning with core commercial cycle, and underpinning manufacturing and commercial financial plan assumptions alignment. • Lead Pharma end to end and logistic supply chain finance, collaborating with global logistic, procurement, Pharma regional logistics leads and E2E finance to enhance supply chain end to end performance, and delivering year on year £20m cost to serve benefits.• Finance lead for GMS portfolio optimization work stream in CEO Pharma future strategy. Working across GMS functions, commercial teams and external consultants to deliver future Pharma portfolio simplification strategies. • Finance partner with classic and established portfolio (CEP) strategy team to run option analysis, influencing decision making to define the strategy and profile CEP products across emerging markets.

Rtp, Nc

• Develop GSK pricing and contracting analytics platform to enable quicker pricing decisions and pricing transparency across GSK. Driving improvement in pricing analytics and price governance. • Lead cross functional team from finance, market access, pricing and regional/local commercial to develop GSK Global Pharma price definitions and gross to net taxonomies. It drove company wise consistency, enabled price transparency and sale performance analysis at sub-national level cross countries. • Responsible for the design of various pricing analyses and pricing reporting tools for major European and Emerging markets for 17 different products cross respiratory, HIV and classic brands. It delivers accurate price reporting tool and strategic price decisions. • Developed price volume mix analysis training module to local finance team. Enable local finance partner to understand various factors in pharmaceutical products pricing strategies and price volume impact on product profit deliveries.

Parsippany, New Jersey

• Manage GSK US over the counter products P&Ls to ensure delivery of sales, profit and margin targets.• Developed comprehensive financial valuation for new product launch. Engaged with marketing research, global supply chain and marketing team to develop high quality business cases. Successfully partnering with brand teams to launch four products within a year. • Analyzed return on investment and price volume strategy for various marketing campaigns and promotions in all retail channels. Recommended new promotional strategies to achieve higher ROIs. • Worked with brand team and US manufacture site on SKU optimization based on SKU level sale, margin and manufacturing capacity analyses. Successfully delivered product optimization strategy for over 120 SKUs, and reduced more than 50% of production turnover time. • Partnered with marketing and sales team to successfully deliver 3 year bottom up financial planning. • Responsible for monthly close and forecast, manage marketing brand spend compliant to US GAAP. Forecast accuracy remained higher than 95%. • Guide and mentor associate brand managers for brand financial P&L management, enabling brand managers to make reasonable financial judgment.

New Brunswick, Nj

• Managing several projects outsourced to Piramal Healthcare Ltd to ensure the portfolio delivery within time constrains. Ensured data received from Piramal is valid and accurate for BMS internalproduct development.• Investigated and successfully developed modified release tablets for cardio vascular disease for Phase 2 clinical trials.• Researched alternative drug delivery technologies to enhance the bio-absorption of a poorly water soluble Alzheimer drug(potential Blockbuster drug). Successfully developed the first solid dispersion tablet going into Phase 3 clinical trials.• Received Chemistry Leadership Award for leading the chemical degradation studies of a drug candidate. Analyzed the degradation through experiments and excel modeling. Successfully provided the mechanistic understanding and delivered recommendations to management to mitigate the risks for the final product.

• Evaluate feasibility of alternative drug delivery technologies for bioavailability enhancement of poorly soluble compounds through solid dispersion dosage formulations. • Lead the chemical degradation studies of active pharmaceutical ingredients, provided the mechanistic understanding and kinetics modelling to mitigate the risk for final drug products. • Enable the portfolio delivery in a timely manner. Execute exploratory biopharmaceutical responsibilities for compounds entering early development stage, such as including form selection, initial drug substance characterization, excipient compatibility, tox and FIH formation development.

Master, Master Of Business Administration

Activities and Societies: Investment Management Research Society, Pharmaceutical and Healthcare Association, and Graduate Finance.

Master In Analytical Chemistry, Analytical Chemistry

Masters, Analytical Chemistry

Bachelor Of Science (Bs), Chemistry